Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
KNTE
KNTE News & Events
-
Add to Watchlist
Trade KNTE
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Forecast
Technical
Valuation
Financials
Earnings
Should I Buy
News
KNTE News
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates FREE, HRT, NGM, KNTE
Mar 18 2024
PRnewswire
Kinnate Biopharma Inc. vende su inhibidor Pan-RAF en fase de investigación, exarafenib, a Pierre Fabre Laboratories
Mar 04 2024
PRnewswire
Kinnate Biopharma Inc. verkauft seinen in der Entwicklung befindlichen Pan-RAF-Inhibitor, Exarafenib an Pierre Fabre Laboratories
Mar 04 2024
PRnewswire
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates DFS, COF, KNTE
Feb 21 2024
PRnewswire
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kinnate Biopharma Inc.
Feb 16 2024
PRnewswire
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kinnate Biopharma Inc.
Feb 16 2024
PRnewswire
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates HRT, KNTE, CALB
Feb 16 2024
PRnewswire
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates HRT, KNTE, CALB
Feb 16 2024
PRnewswire
Show More News
KNTE Events
No data
KNTE Monitor News
No data
KNTE Earnings Analysis
No Data
People Also Watch